Skip to main content
Marianne van den Bree

Professor Marianne van den Bree

(she/her)

Users
Available for postgraduate supervision

Teams and roles for Marianne van den Bree

  • Professor, Division of Psychological Medicine and Clinical Neurosciences

    School of Medicine

Overview

I am a Professor of Psychological Medicine within the Division of Psychological Medicine and Clinical Neurosciences, the MRC Centre for Neuropsychiatric Genetics and Genomics and the Neuroscience and Mental Health Research Institute at Cardiff University.

My research focuses on the characterisation of the genetic and environmental factors that play a role in the development of mental health disorders. This includes understanding the complex developmental relationships across the lifespan between mental health disorders and other health-related conditions.

My background is in psychology, human genetics and epidemiology/methodology.

I am interested in the wide-ranging developmental, behavioural, cognitive and psychiatric and physical health manifestations that can be experienced by people with rare genomic variants, including chromosomal microdeletions and duplications known as Copy Number Variants (CNVs).

I have extensive experience playing lead roles in international consortia studying CNV and mental health.

A key aim is also to communicate mental health research findings widely and strive for societal benefit.

Publication

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

1999

1998

1996

1990

1989

Articles

Conferences

Websites

Research

Lead roles

LIfespaN multimorbidity research Collaborative (LINC)

I lead the LINC programme grant, bringing together researchers from Cardiff, Bristol, Leeds, Queen Mary London, and Exeter Universities and the Wellcome Sanger Institute in the UK as well as Roskilde University in Denmark. LINC studies the development of physical and mental health multimorbidity across the lifespan. The programme involves analysis of eight large longitudinal cohorts (combined sample size ~7 million) to evaluate the role of genetic and environmental factors on risk of multimorbidity development.

https://www.cardiff.ac.uk/news/view/2524833-funding-success-for-cardiff-university-researchers-who-will-study-the-link-between-physical-and-mental-health-problems

Cardiff ExperieCes of people witH rare genOmic variants (ECHO) Research Programme

I initiated and lead a large-scale longitudinal research programme which studies mental and physical health in people with a range of rare genomic variants linked with increased risk of neurodevelopmental disorder. Participants are recruited through UK Medical Genetics clinics and their family members also take part. This programme combines detailed wide-ranging phenotyping with genetic, cellular, pharmacological and brain imaging studies.

Web page: https://www.cardiff.ac.uk/mrc-centre-neuropsychiatric-genetics-genomics/research/themes/developmental-psychiatry/copy-number-variant-research-group

IMAGINE-ID

Cardiff Lead Investigator of the Assessing Genomic Impact on Neurodevelopment (IMAGINE-ID) study (collaboration with D. Skuse (University College London)).

Medical Research Council (MRC)-funded.

Web page:  https://imagine-id.org/

Genes to Mental Health (G2MH) Network

Principal Investigator of one of a cluster of nine NIMH RO1 grants studying the mental health and neurocognitive profiles of individuals with 16p11.2 and 22q11.2 deletion or duplication (collaboration with R. Gur (University of Pennsylvania), including Universities of California (at Los Angeles and San Diego) and Children’s Hospital of Philadelphia in the USA, universities of Toronto and Montreal in Canada, Katholieke Universiteit Leuven in Belgium and Maastricht University in The Netherlands.

National Institute of Mental Health USA (NIMH)-funded.

Website: genes2mentalhealth.com

Biomarkers for intellectual disability and autism spectrum disorder in deletion and duplication of 16p11.2

Phenotyping Work Package Lead of a research programme studying signalling pathways in individuals with 16p11.2 deletion or duplication (collaboration with R. Brambilla (Cardiff University)).

MRC-funded.

Knowledge Transfer Partnership

Partnership with support charity CEREBRA to improve mental health for children with neurodevelopmental disabilities linked with CNV.

Innovate UK and CEREBRA funded.

Website: https://cerebra.org.uk/what-we-do/research/our-research-partners/cardiff-university/

Experience playing lead roles in international consortia:

  • International Genes to Mental Health Consortium (G2MH)(Site Lead)
  • Physical and mental health multimobidity across the lifespan (LIfespaN multimorbidity research Collaborative (LINC))(Lead)
  • Mental Health NIMH Rare Genetic Disease Network (MHRGDN) Steering Committee (Member)
  • 22q11.2 Deletion Syndrome International Brain and Behavior Consortium (IBBC)(Coordinator of half of EU sites)
  • Pan-EU MINDDS Consortium (Work Package Lead)

 Other memberships:

  • Wales Kidney Research Unit at Cardiff University
  • Principal Collaborator Born in Bradford Age of Wonder Programme at the University of Leeds
  • Academic Partner Cleft Collective Cohort at Bristol University

Selected recent Funding:

The Waterloo Foundation, Developing Minds. PI J. Hall. My role: Co-I: £1,250,512.

Health and Care Research Wales Sustainability Award. Wales Kidney Research Unit. PI: D. Fraser. My role: Co-I, £2.984,527.

Wellcome Trust. Characterising the clinical heterogeneity and aetiology of avoidant restrictive food intake. PI: S. Chawner. My role: Co-I. £3,965,962

Wellcome Trust. Deep microstructural phenotyping of the developing mind (BEAM study). PI: D. Jones. My role: Co-PI. £5,987,599

Wellcome Trust. The Sleep Detectives: Sleep stratification in young people at high risk of psychosis. PI: M. Jones. My role: Co-I. £932,252.

MRC. The impact of schizophrenia-associated Copy Number Variants on cortical network dynamics (CONVERGE study). PI: J. Hall. My role: Co-I. £2,449,454.

MRC, ESRC, NIHR. Physical and mental health multimorbidity across the lifespan (LIfespaN multimorbidity research Collaborative: LINC). My role: PI. £3,631,451

MRC. Improving mental health outcomes in children born with orofacial cleft: Identifying children at most risk to target clinical provision. PI: E. Stergiakouli. My role: Co-I. £748,523

MRC, ESCR, NIHR. Investigating five large population-based cohort studies to understand the precursors of multimorbidity risk. My role: PI. £74,363.78

MRF. The relationship between the 16p11.2 locus and eating disorders: novel insights from rare genetic conditions. PI: S. Chawner. My role: Co-I. £288,106.

MRC. IMAGINE-2: Stratifying Genomic Causes of Intellectual Disability by Mental Health Outcomes in Childhood and Adolescence. PI: D. Skuse. My role: Co-I, Lead of Work Package 2 (face-to-face phenotyping). £1,999,599.26

Wellcome Trust ISSF. Using genomics to understand the early developmental origins of psychiatric conditions. PI: S. Chawner. Role: My role: Research sponsor. £69,443.

NIMH. Supplement to 7/9: Dissecting the effects of genomic variants on neurobehavioral dimensions in CNVs enriched for neuropsychiatric disorders. Subcontract to Children’s Hospital of Philadelphia (CHOP). My role: PI: $41,833.80

MRC. Targeting ERK signalling to ameliorate intellectual disability and autism spectrum disorder associated with chromosomal rearrangements at 16p11.2. PI: R. Brambilla. My role Co-I, Lead of Work Package 1 (face-to-face phenotyping). £1,181,767.

NIMH. RO1(7) is: 7/9 Dissecting  the  effects  of  genomic  variants  on  neurobehavioral  dimensions  in  CNVs  enriched  for  neuropsychiatric disorders. PI: R. Gur. My role: PI. $6,000,000 ($1,477,560 to Cardiff directly).

Baily Thomas Charitable Trust. Pilot study to develop and instrument to capture broad-ranging neurodevelopmental problems in children with a genetic diagnosis of intellectual disability. My role: PI. £48,502.

Takeda. To establish a scalable set of assay platforms against which the phenotype consequences of manipulating the identified exclusive targets can be screened and effects the drug compounds assessed to develop therapeutics for schizophrenia. PI: L. Wilkinson. My role: Co-I.  £2,960,749.

Innovate UK, CEREBRA. Knowledge Transfer Partnership (KTP). Improving mental health for children with neurodevelopmental disabilities: A Knowledge Transfer Partnership between Cerebra and Cardiff University. My role: PI. £216,320.

European Union Cooperation in Science and Technology (COST). Maximising Impact of research in Neuro-Developmental DisorderS (MINDDS). PI: A. Harwood. My role: Management Committee Member and Leader of Working Group 2.

MRC. Intellectual disability and mental health: assessing genomic impact on neurodevelopment (IMAGINE study). Pi: D. Skuse. My role: Co-PI. £3,127,715.

Teaching

Teaching experiences include:

The epidemiology and biology of substance misuse (medical students at Cardiff University).

CNVs and mental health risk (PhD students).

I have led the medical intercalated degree of Psychology and Medicine at Cardiff University

 

Biography

Education:

  • BSc Psychology, Vrije Universiteit, Netherlands
  • MSc Experimental Psychology, Vrije Universiteit, Netherlands
  • PhD, Human Genetics, Medical College of Virginia - Virginia Commonwealth University, Richmond, VA.

Awards:

  • RCUK Societal Impact Award, KTP 40th Anniversary Awards (2015)
  • Cardiff University Social Innovation Award (2015)
  • Research project ‘Improving mental health services for homeless people’ received highest grade of "Outstanding" by the KTP Grading Panel for achievement in meeting KTP's Objectives (2014)
  • European Research Advisory Board Publication Award (2013)

Academic positions:

  • Impact Lead Institute of Psychological Medicine and Clinical Neurosciences
  • School of Medicine REF Management Group Member

Supervisions

I have thus far successfully supervised 14 PhD students Primary Supervisor) and clinical fellows.

You are welcome to contact me if you are looking to do a PhD in a vibrant research group and you are interested in:

  • Genetics
  • Mental Health
  • Cognition
  • Rare genetic syndromes
  • Mental and physical health multimorbidity
  • Epidemiology
  • Longitudinal research

 

 

Current supervision

Engagement

UKRI SKey Note Presentations:

  • Society for the Study of Behavioural Phenotypes (SSBP), Amsterdam, Netherlands (2025)
  • International Congress Royal College of Psychiatrists, Newport (2025)
  • Launch Paediatric Mental Health Sceince Centre, UCL, Great Ormond Street Institute of Child Health, London (2025)
  • Rare Disase Conference, Stockholm, Sweden (2025)
  • Lectio Magistralis at the Festival Della Scienza, Genoa, Italy (2020).
  • CEREBRA lecture, Cardiff (2019)
  • International Medical Advisory Group (IMAG) conference, Amsterdam (2014)
  • Faculty of Addictions Psychiatry Annual Conference 2012, Cardiff (2012)
  • International Medical Advisory Group (IMAG) conference, Frascati, Italy (2010)
  • Inter Celtic Congress, St Malo, France (2007).
  • Annual Meeting of the Royal College of Psychiatrists, Glasgow, Scotland (2006)

Selected Other Presentations:

  • Multiple Long-Term Conditions conference organised by NIHR and UKRI, Birmingham (2025)
  • Multiple Long-Term Conditions Symposium for analysis of multimorbidity research, Leicester (2025)
  • Launch Neuroscience and Mental Health Innovation Institute, Cardiff University, Cardiff (2023)
  • Neurodevelopmental disorders: from molecular mechanisms to social inclusion. 7th Bordeaux Neurocampus Conference. Bordeaux University, Bordeaux, France (2023)
  • Future MINDDS: Recent advances and future directions for resereach of neurodevelopmental disorders associated with pathogenic Copy Number Variants, Cardiff (2022)
  • COST Enhancing Psychiatric Genetic Counslling, Testing and Training in Europe (EnGagE) Consortium meeting (online)
  • Welsh paediatric Society meeting, Cardiff (2021)
  • ‘What I know best’ congress, lectures Medical Geneticists, Rome, Italy (2020).
  • Cleft Collective Cohort Studies, Bristol (2019)
  • Panel Member at the 10-year celebration event of the MRC Centre for Neuropsychiatric Genetics and Genomics, Cardiff (2019)
  • European Society for Child and Adolescent Psychiatry (ESCAP) congress, Vienna, Austria (2019)
  • Waterloo Foundation "Changing Minds" symposium, Cardiff (2019)
  • 22q Northern Ireland charity family and clinician day, Belfast (2019)
  • Centre for Genomic Medicine clinical meeting, Manchester (2018).
  • NMHRI Centre Neurodevelopmental Disorder Research Day at to celebrate the opening of the new Child Development Centre, Cardiff (2018)
  • Presentation to Belgium Ambassador in the UK, Ambassador Rudolf Huygelen, Cardiff (2017)
  • 16p11.2 family day, Cardiff (2016)
  • MRC Centre for Neuropsychiatric Genetics and Genomics External Advisory Board, Cardiff (2016)
  • Medical Genetics Regional Genetics Centres, London (2016).
  • Royal College of Psychiatrists International Conference, London (2016)
  • National Centre for Mental Health (NCMH), Cardiff (2016).
  • 22q11.2 Deletion Syndrome family meeting. MaxAppeal! (2015)
  • European College of Neuropsychopharmacology (ECNP), Amsterdam (2015)
  • Waterloo Foundation - Neurodevelopmental Disorders and Therapies Event, Cardiff (2015)
  • Genetics Update for Paediatricians meeting, Cardiff (2014)
  • 22q11.2 Deletion Syndrome family meeting. MaxAppeal!, Stourbridge (2015)
  • Guys Hospital, London (2014)
  • South West of Britain Clinical Genetics Group meeting, Cardiff (2013)
  • Fourth Cardiff Symposium on Clinical Cardiovascular Genetics “Current Trends in Diagnosis and Therapy of Inherited Cardiovascular Disorders”, Cardiff (2013)
  • Open University Symposium on Psychosis. UK Research Highlights Session. Brain and Behavioural Sciences series, Milton Keynes (2013)
  • South East Dysmorphology group (Kleefstra Syndrome Meeting), Guy’s Hospital, London (2013).

Selected Other Engagement:

Contact Details

Email VANDENBREEMB@cardiff.ac.uk
Telephone +44 29206 88433
Campuses Hadyn Ellis Building, Room 2.16, Maindy Road, Cardiff, CF24 4HQ

Specialisms

  • Psychiatric Genetics
  • Multimorbidity
  • longitudinal research